Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities

Chimeric antigen receptor (CAR) therapies such as tisagenlecleucel, indicated for children and young adults with relapsed and/or refractory CD19(+) acute lymphoblastic leukemia (ALL), have been associated with striking treatment outcomes and overall survival. Yet, they are also associated with uniqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Harden, Avis, Ragoonanan, Dristhi, Anildes-Gubman, Daryl, McCall, David, Faltus, Kathleen, Featherston, Sarah, Shoberu, Basirat, Moffet, Jerelyn R., Petropoulos, Demetrios, Khazal, Sajad J., Razvi, Shehla, Mahadeo, Kris M., Tewari, Priti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419673/
https://www.ncbi.nlm.nih.gov/pubmed/32850365
http://dx.doi.org/10.3389/fonc.2020.01227

Ejemplares similares

Ejemplares similares